{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:50:31Z","timestamp":1787590231173,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Niger J Clin Pract"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/1119-3077.164351","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T01:57:56Z","timestamp":1441245476000},"page":"237","source":"Crossref","is-referenced-by-count":3,"title":["Frequency and clinical impact of ETV6\/RUNX1, AF4-MLL, and BCR\/ABL fusion genes on features of acute lymphoblastic leukemia at presentation"],"prefix":"10.4103","volume":"19","author":[{"given":"AJ","family":"Madu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IC","family":"Ajuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Okocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OG","family":"Ibegbulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Okpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OE","family":"Nna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1119-3077.164351-1","first-page":"554","volume-title":"SEER update of incidence and trends in pediatric malignancies: Acute lymphoblastic leukemia","author":"McNeil","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"key-10.4103\/1119-3077.164351-2","unstructured":"Smith MA, Ries LAG. Cancer Incidence and Survival among Children and Adolescents. United States SEER Program 1975-1995. Cancer Statistics Branch, Cancer Surveillance Research Program, Division of Cancer Control and Population Sciences. Bethesda, MD: National Cancer Institute; 1999. p. 17-34."},{"key":"key-10.4103\/1119-3077.164351-3","first-page":"491","volume-title":"Biology and treatment of acute lymphoblastic leukemia","author":"Pui","year":"1994","journal-title":"J Pediatr"},{"key":"key-10.4103\/1119-3077.164351-4","unstructured":"Margolin JF, Steuber CP, Poplack DG. Acute lymphoblastic leukemia. Principles and Practice of Pediatric Oncology. 15th ed. 2006:538-90."},{"key":"key-10.4103\/1119-3077.164351-5","doi-asserted-by":"crossref","unstructured":"Omoti CE, Imiere EO Trends in the pattern of leukaemia incidence in a tertiary health center in Nigeria (1990-2004). J Med Biomed Res 2006;5:44-9.","DOI":"10.4314\/jmbr.v5i2.10692"},{"key":"key-10.4103\/1119-3077.164351-6","first-page":"89","volume-title":"Neoplastic diseases of the haemopoietic system in Ibadan: Preliminary report of a prospective study","author":"Williams","year":"1985","journal-title":"Afr J Med Med Sci"},{"key":"key-10.4103\/1119-3077.164351-7","first-page":"265","volume-title":"Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000","author":"M\u00f6ricke","year":"2010","journal-title":"Leukemia"},{"key":"key-10.4103\/1119-3077.164351-8","first-page":"363","volume-title":"Detecting ALK, ROS1 and RET fusion genes in cell block samples","author":"Zhao","year":"2014","journal-title":"Transl Oncol"},{"key":"key-10.4103\/1119-3077.164351-9","first-page":"1","volume-title":"Childhood acute lymphoblastic leukemia: Update on prognostic factors","author":"Vrooman","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"key-10.4103\/1119-3077.164351-10","first-page":"2014","volume-title":"Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: Absence of the ALL1\/AF4 and of the BCR\/ABL fusion genes correlates with a significantly better clinical outcome","author":"Cimino","year":"2003","journal-title":"Blood"},{"key":"key-10.4103\/1119-3077.164351-11","first-page":"86","volume-title":"ETV6-RUNX1 fusion gene and additional genetic changes in infant leukemia: A genome-wide analysis","author":"Emerenciano","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"key-10.4103\/1119-3077.164351-12","first-page":"520","volume-title":"Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: A UK Cancer Cytogenetics Group Study","author":"Harrison","year":"2005","journal-title":"Br J Haematol"},{"key":"key-10.4103\/1119-3077.164351-13","first-page":"700","volume-title":"Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements","author":"Pui","year":"2003","journal-title":"Leukemia"},{"key":"key-10.4103\/1119-3077.164351-14","first-page":"1985","volume-title":"TEL\/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis","author":"Shurtleff","year":"1995","journal-title":"Leukemia"},{"key":"key-10.4103\/1119-3077.164351-15","first-page":"\/\/dx","volume-title":"An Audit of Acute Leukaemias at the University College Hospital, Ibadan, Nigeria.Open access scientific reports","author":"Olaniyi","year":"8220","journal-title":"HYPERLINK"},{"key":"key-10.4103\/1119-3077.164351-16","first-page":"2","volume-title":"Clinical and Laboratory Characteristics of Patients with Leukaemia in South-South Nigeria.The Internet Journal of Oncology","author":"Nwannadi","year":"2011","journal-title":""},{"key":"key-10.4103\/1119-3077.164351-17","first-page":"313","volume-title":"Prognosis of acute lymphoblastic leukaemia in Ibadan, Nigeria","author":"Okpala","year":"1990","journal-title":"Afr J Med Med Sci"},{"key":"key-10.4103\/1119-3077.164351-18","first-page":"89","volume-title":"Neoplastic diseases of the haemopoietic system in Ibadan: Preliminary report of a prospective study","author":"Williams","year":"1985","journal-title":"Afr J Med Sci"},{"key":"key-10.4103\/1119-3077.164351-19","first-page":"5742","volume-title":"Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: Results from ALL-BFM 90 and 95","author":"Schrauder","year":"2006","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/1119-3077.164351-20","first-page":"1070","volume-title":"Acute lymphoblastic leukemia in infancy","author":"Silverman","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"key-10.4103\/1119-3077.164351-21","first-page":"4263","volume-title":"Blood","author":"Romana","year":"1995","journal-title":""},{"key":"key-10.4103\/1119-3077.164351-22","doi-asserted-by":"crossref","unstructured":"Noreen S, Zafar I, Aamer A, Tashfeen A, Tahir N, Sultan A, et al. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukaemia and their association with disease biology and outcome. Asian Pacific J Cancer Prev 2012;13.7:3349-55.","DOI":"10.7314\/APJCP.2012.13.7.3349"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:34Z","timestamp":1786650034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1119-3077.164351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["164351"],"URL":"https:\/\/doi.org\/10.4103\/1119-3077.164351","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}